![Christopher Vann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Vann
Geschäftsführer bei
AUTOLUS THERAPEUTICS PLC
Vermögen: 359 435 $ am 31.05.2026
Profil
Christopher Vann currently works at Alliance for Regenerative Medicine, as Treasurer & Director from 2023 and Autolus Therapeutics Plc, as Chief Operating Officer & Senior Vice President from 2016.
Mr. Vann also formerly worked at Roche Holding AG, as Commercial Director from 1994 to 2016.
Mr. Vann received his undergraduate degree from School of Pharmacy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2026 | 192’211 ( 0.12% ) | 359 435 $ | 31.05.2026 |
Aktive Positionen von Christopher Vann
| Unternehmen | Position | Beginn |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Geschäftsführer | 01.10.2016 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktor/Vorstandsmitglied | 01.01.2021 |
Ehemalige bekannte Positionen von Christopher Vann
| Unternehmen | Position | Ende |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01.09.2016 |
Ausbildung von Christopher Vann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
School of Pharmacy
 School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
